www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

Chinadaily.com.cn
 
Go Adv Search

China's mums key to Nestle baby milk deal

Updated: 2012-04-25 11:19

(Agencies)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

主站蜘蛛池模板: 亚洲一区二区三区精品视频 | 国产成年人在线观看 | 美国大毛片 | 成年人网站黄 | 国产成人在线影院 | 成人国产一区二区三区精品 | 日本三级网站 | 国产成人a毛片 | 91视频欧美 | 韩国视频一区 | 日韩一级在线 | 精品久久久久久久久中文字幕 | 在线观看国产情趣免费视频 | 精品视频一区二区三区在线观看 | 久久国内精品视频 | 国产v片在线播放免费观 | 99视频精品免视3 | 免费中文字幕 | 国产免费久久 | 国产激情一区二区三区成人91 | 草草影院欧美三级日本 | 亚州一级毛片在线 | 国产亚洲欧美ai在线看片 | 日本一区二区三区高清在线观看 | 新版天堂中文资源8在线 | a高清免费毛片久久 | 欧美整片在线 | 国产精品免费一区二区三区 | 18视频免费网址在线观看 | 韩国一级做a爰片性色毛片 韩国一区在线 | 成人毛片网 | 自拍偷自拍亚洲精品一区 | 欧美特黄一级aa毛片 | 国产九九精品视频 | 欧美三级一区二区三区 | 手机看片成人 | 国产亚洲精品美女一区二区 | 一级女性全黄生活片免费 | 欧美日韩一区二区三区久久 | 国产精品手机在线播放 | 韩国巨胸女三级视频网 |